This FDA funding opportunity aims to enhance the predictability of food-drug and drug-drug interaction risks by utilizing in vitro simulated gastrointestinal dissolution models specifically for high-risk oral drug products. The grant allows for an optional clinical trial component. Detailed eligibility and application requirements are not provided in the listing.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
